I've gone back over all of SCU's quarterlies from September 2016...

I've gone back over all of SCU's quarterlies from September 2016 showing quarterly revenue consecutively and I've noted figures below to give a snapshot where revenue increased and decreased for whatever reasons that may have been apparent.

Ive noticed SCU was showing a steady increase in revenue, quarter on quarter for the 2017 financial year until the 2018 December quarter that showed a decrease but then the 2019 March quarter made up for that with a rather large jump up (in comparison to previous quarters) in revenue where it increased to $870,000 (possibly from timing of funds received).

2019 June quarter shows a rather large decrease again and then the 2019 September quarter shoots up again to $557,000.

Financial year ending 2020 looked to be gearing up as a good year but then we had the issues of COVID-19 fall upon us.

The last two quarterlies showing a huge jump up in revenues mostly attributed to the 51% acquisition of Lantene, the Sea Grape cultivation company in China.

SCU management have managed to build revenue, regardless of the issues of COVID-19.

That's proved to me these guys are capable of producing value for us share holders no matter what, IMO!

I would be worried about a company's management and future potential if they were spending millions of dollars, always extracted from share holders or investors of a company, when revenues decline for no particular reason or management just never actually had the ability to increase revenues from commercial contracts to an amount worthy of share holders to keep participating in such capital raises in the first place.

That's clearly not the picture I get from SCU management from doing this quick exercise.






























SCU management appear extremely capable and have gone on to appoint the people they need to realise their current claims in recent announcements as far as Sea Grape and Hemp commercialisation is concerned in the arena of Traditional Chinese Medicine (TCM) in a very, very large Asian Market, IMO.

I really can't complain about revenues shown above or with the job done here by current SCU management in extremely challenging times!

AIMO-GLTAH's



Jocko